drugset / Trial / NCT05052710
Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of Midazolam
NaSingle-groupOpen-labelTreatment
Summary
The study is an open-label, fixed-sequence, cross-over study conducted at a single Clinical Unit to assess the pharmacokinetics (PK) of midazolam in healthy male and female (non-childbearing potential) subjects when administered alone and in combination with AZD4831 after multiple doses (once daily) of AZD4831 for 10 consecutive days.
Timeline
- Start
- 2021-10-05
- Primary completion
- 2021-11-29
- Completion
- 2021-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | Mitiperstat | Small molecule | — | Oral |
Indications
No indication recorded.